IBD cases are on the rise across the globe, even in regions with previously low incidences. First-line treatment largely consists of 5-ASA medications, with patients often escalated to steroids, immunosuppressants, and biological agents. Considering only one-third of patients on conventional therapies achieve remission, researchers and patients alike are exploring complementary and alternative (CAM) solutions to […]
Read more- 1
- 2